FDA Inspection
AltaThera Pharmaceuticals LLCAltaThera Pharmaceuticals LLC – FDA Inspection, Sep 19, 2019
Record Details
This FDA Inspection record concerns AltaThera Pharmaceuticals LLC, with an inspection on September 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 59ec1179-22af-4179-85dc-835301342f1d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1103405
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(a)Contract drug products--lack of responsibility
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AltaThera Pharmaceuticals LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for AltaThera Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.